STRATA Skin Sciences (SSKN) Shares Outstanding (Diluted Average) (2013 - 2025)
STRATA Skin Sciences' (SSKN) quarterly Shares Outstanding (Diluted Average) came in at $4.7 million in Q4 2025, up 22.15% year-on-year from $3.8 million in Q4 2024, and up 8.77% quarter-over-quarter from $4.3 million in Q3 2025.
STRATA Skin Sciences (SSKN) Shares Outstanding (Diluted Average) (2013 - 2025) Analysis & Trends
STRATA Skin Sciences has disclosed Shares Outstanding (Diluted Average) across 11 years of filings, most recently posting $4.7 million for Q4 2025.
- Shares Outstanding (Diluted Average) for Q4 2025 came in at $4.7 million, up 22.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.7 million (up 22.15% YoY), and the FY2025 annual result was $4.7 million, up 22.15% from the prior year.
- Shares Outstanding (Diluted Average) came in at $4.7 million for Q4 2025 at STRATA Skin Sciences, up from $4.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $34.9 million in Q1 2023 to a low of $3.5 million in Q2 2023.
- The 5-year median for Shares Outstanding (Diluted Average) is $4.5 million (2025), against an average of $17.6 million.
- Across the five-year window, Shares Outstanding (Diluted Average) surged 9252691.85% in 2021 and slumped 89.95% in 2023, its largest moves.
- STRATA Skin Sciences' Shares Outstanding (Diluted Average) stood at $34.1 million in 2021, then rose by 1.94% to $34.7 million in 2022, then slumped by 89.94% to $3.5 million in 2023, then increased by 9.03% to $3.8 million in 2024, then increased by 22.15% to $4.7 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $4.7 million (Q4 2025), $4.3 million (Q3 2025), and $4.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn | 4.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.65 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 4.17 Mn |
| Mar 31, 2025 | 4.17 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 3.51 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 34.86 Mn |
| Dec 31, 2022 | 34.71 Mn |
| Sep 30, 2022 | 34.71 Mn |
| Jun 30, 2022 | 34.70 Mn |
| Mar 31, 2022 | 34.68 Mn |
| Dec 31, 2021 | 34.05 Mn |
| Sep 30, 2021 | 34.15 Mn |
| Jun 30, 2021 | 33.84 Mn |
| Mar 31, 2021 | 33.80 Mn |